36C10G25Q0045_1.docx

DOCX document 18 KB Posted

Attached to
Q301--Minimal Residual Disease (MRD)/Testing Services
Solicitation number
36C10G25Q0045
Issued by

About this file

This is a Sources Sought Notice from the Department of Veterans Affairs (VA) seeking information about contractors capable of providing Minimal Residual Disease (MRD) testing services for colon cancer patients. The VA's National Oncology Program office requires specialized laboratory services for molecular MRD testing to guide post-resection treatment decisions for stage II colorectal cancer patients. Testing methods include next generation genetic sequencing, flow cytometry, and polymerase chain reaction (PCR).

Responses are due by February 13, 2025, at 2:00 PM EST to Michelle Bailey and Zachary Wilcox. Contractors must demonstrate experience with molecular testing in New York State and preferably hold CLIA certification to service all 50 states, DC, and Puerto Rico. The NAICS code is 621511 (Medical Laboratories). Respondents must provide company information, socio-economic status, proof of peer-reviewed data supporting test validity, experimental status of testing, and a capabilities statement. This is an RFI only under solicitation number 36C10G25Q0045, with no set-asides specified, and the place of performance is throughout the Continental United States.

View the file

Other files

File Type Posted
36C10G25Q0045_2.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Sources Sought Notice Sources Sought Notice

SUBJECT*
Minimal Residual Disease (MRD)/Testing Services

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
22408-2697
SOLICITATION NUMBER*
36C10G25Q0045
RESPONSE DATE/TIME/ZONE
01-31-2025 10am EASTERN TIME, NEW YORK, USA
ARCHIVE
15 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N

SET-ASIDE

PRODUCT SERVICE CODE*
Q301
NAICS CODE*
621511
CONTRACTING OFFICE ADDRESS
U.S. Department of Veterans Affairs

OPAL | Strategic Acquisition Center

10300 Spotsylvania Ave | STE 400 Fredericksburg VA 22408-2697

POINT OF CONTACT*

Contract Specialist Michelle Bailey michelle.bailey@va.gov 202-746-1251

PLACE OF PERFORMANCE

ADDRESS
Throughout the Continental United States

POSTAL CODE

COUNTRY
USA

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS
michelle.bailey@va.gov
EMAIL DESCRIPTION
MRD Testing Services

DESCRIPTION

Sources Sought Notice: National Precision Oncology Program: Minimal Residual Disease (MRD)/Testing Services

THIS IS A REQUEST FOR INFORMATION (RFI) ONLY. This Sources Sought Notice is issued solely for information and planning purposes it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. This notice does not commit the Government to contract for any supplies/or services whatsoever. Furthermore, the Government is not at this time seeking proposals and will not accept unsolicited offers. Interested vendors are advised that the Government will not pay for any information or administrative costs incurred in the response to this Notice. All costs associated with responding to this notice will be solely at the interested party’s expense. Not responding to this notice does not preclude participation in any future RFP, if issued. If a solicitation is released, it will be synopsized on https://www.sam.gov. It is the responsibility of the potential offerors to monitor this site for additional information pertaining to this requirement.

The Department of Veterans Affairs (VA), National Oncology Program office is conducting market research to identify potential contractors that may possess the expertise, capabilities, and experience for the acquisition of specialized, comprehensive reference laboratory services from contractor(s) with the capability and expertise to provide molecular testing for Minimal Residual Disease (MRD) testing for patients diagnosed with colon cancer. Colon cancer is One of the top 3 cancers diagnosed in Veterans. MRD testing in stage II colorectal cancers post resection has been shown to help guide management decisions regarding the need for adjuvant chemotherapy.

There are different methods that are used to detect MRD, including:

· Next generation genetic sequencing: Analyzes bone marrow samples for genetic mutations.

· Flow cytometry: Looks for abnormal proteins on the surface of cells.

· Polymerase chain reaction (PCR): Amplifies small amounts of DNA to make it easier to detect and count.

The choice of method depends on the type of cancer and its molecular signatures.

Contractor(s) that respond to this RFI must provide specifically demonstrated history of molecular testing of samples from patients in New York State and is preferably certified through Clinical Laboratory Improvement Amendments (CLIA) to service all 50 states to include, the District of Columbia, and Puerto Rico.

The North American Industry Classification System Code (NAICS) Code for this requirement is 621511, Medical Laboratories. The information that is received from this notice will be used to make the best decision on how to proceed with this acquisition. Information received will not be shared with other potential offerors. If your firm is interested in this RFI and can provide the testing service as stated, please respond to this post to Michelle Bailey, at michelle.bailey@va.gov and Zachary Wilcox, Zachary.wilcox@va.gov. The closing date of this RFI will be February 13, 2025, 2pm EST. All responses will need to be submitted by the closing to the provided contracting staff.

Requested Information

Company Name:

Point of Contact Information:

Name:
Email:
Phone Number:

Cage Code:

Company Socio-Economic Status (i.e. Woman Owned, Veteran Owned, Disabled Veteran Owned, etc):

Company Business Size for NAICS Code:

Does your MRD testing have published, peer-reviewed data supporting the validity of the test? If yes, please provide the publication reference.

Is your MRD Testing considered to be experimental in nature?

Please provide a copy of your capabilities statement for your company when replying to this posting.

*= Required Field
Sources Sought Notice

Sources Sought Notice

File details come from the government source that posted it. Updated .